HRP20040570A2 - Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment - Google Patents

Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment

Info

Publication number
HRP20040570A2
HRP20040570A2 HR20040570A HRP20040570A HRP20040570A2 HR P20040570 A2 HRP20040570 A2 HR P20040570A2 HR 20040570 A HR20040570 A HR 20040570A HR P20040570 A HRP20040570 A HR P20040570A HR P20040570 A2 HRP20040570 A2 HR P20040570A2
Authority
HR
Croatia
Prior art keywords
preparation
betacyclodextrin
steroidal anti
inflammatory drug
microwave treatment
Prior art date
Application number
HR20040570A
Other languages
English (en)
Inventor
Ferdinando Giordano
Ruggero Bettini
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of HRP20040570A2 publication Critical patent/HRP20040570A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/4935—Impregnated naturally solid product [e.g., leather, stone, etc.]
    • Y10T428/662—Wood timber product [e.g., piling, post, veneer, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adornments (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
HR20040570A 2001-12-21 2004-06-18 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment HRP20040570A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002749A ITMI20012749A1 (it) 2001-12-21 2001-12-21 Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut
PCT/EP2002/014349 WO2003053475A1 (fr) 2001-12-21 2002-12-17 Procede pour l'elaboration de composes d'insertion constitues d'un medicament anti-inflammatoire non steroide et de betacyclodextrine, par traitement aux hyperfrequences

Publications (1)

Publication Number Publication Date
HRP20040570A2 true HRP20040570A2 (en) 2004-10-31

Family

ID=11448736

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040570A HRP20040570A2 (en) 2001-12-21 2004-06-18 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment

Country Status (15)

Country Link
US (1) US7935685B2 (fr)
EP (1) EP1455838B1 (fr)
CN (1) CN100528236C (fr)
AT (1) ATE395086T1 (fr)
AU (1) AU2002356663A1 (fr)
BR (1) BR0207630A (fr)
CA (1) CA2470992A1 (fr)
DE (1) DE60226637D1 (fr)
HK (1) HK1079992A1 (fr)
HR (1) HRP20040570A2 (fr)
IT (1) ITMI20012749A1 (fr)
MX (1) MXPA04005883A (fr)
NO (1) NO20033669L (fr)
PL (1) PL370706A1 (fr)
WO (1) WO2003053475A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116247A1 (fr) * 2005-04-25 2006-11-02 Teva Pharmaceuticals Usa, Inc. Preparations a liberation prolongee
CN100424453C (zh) * 2005-08-06 2008-10-08 天水华圆制药设备科技有限责任公司 带有双干燥室的微波真空连续干燥机及其使用方法
CN100443839C (zh) * 2005-08-06 2008-12-17 天水华圆制药设备科技有限责任公司 安全节能的微波真空自动连续干燥机
US7781572B2 (en) * 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
US7658913B2 (en) * 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
US8192721B2 (en) * 2007-12-13 2012-06-05 Verrow Pharmaceuticals, Inc. Compositions useful for reducing toxicity associated with gadolinium-based contrast agents
CN102181078A (zh) * 2010-12-29 2011-09-14 天津科技大学 一种提高沃氏氧化物生物催化效率的包合物制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241088B (it) * 1990-03-27 1993-12-29 Chiesi Farma Spa Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5665767A (en) * 1993-03-05 1997-09-09 Hexal Pharma Gmbh Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica
DE4428654A1 (de) * 1994-08-12 1996-02-15 Consortium Elektrochem Ind Wasserlösliche Cyclodextrinderivate mit lipophilen Substituenten und Verfahren zu ihrer Herstellung
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
WO2002013792A1 (fr) * 2000-08-11 2002-02-21 Eisai Co., Ltd. Dispersion solide médicamenteuse à solubilité accrue

Also Published As

Publication number Publication date
US20070059547A9 (en) 2007-03-15
PL370706A1 (en) 2005-05-30
US7935685B2 (en) 2011-05-03
HK1079992A1 (en) 2006-04-21
EP1455838A1 (fr) 2004-09-15
BR0207630A (pt) 2004-06-01
AU2002356663A1 (en) 2003-07-09
CN100528236C (zh) 2009-08-19
US20050042471A1 (en) 2005-02-24
NO20033669L (no) 2003-10-17
CA2470992A1 (fr) 2003-07-03
NO20033669D0 (no) 2003-08-19
MXPA04005883A (es) 2004-11-01
WO2003053475A1 (fr) 2003-07-03
CN1638806A (zh) 2005-07-13
ITMI20012749A1 (it) 2003-06-21
EP1455838B1 (fr) 2008-05-14
DE60226637D1 (de) 2008-06-26
ATE395086T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
HK1079992A1 (en) Process for preparation of inclusion compounds between a non-steroidal anti-inflam-matory drug and betacyclodextrin by microwave treatment
NO20002409L (no) FremgangsmÕte for Õ produsere arsen trioksyd formuleringer og metoder for Õ behandle cancer ved Õ bruke arsen trioksyd eller melarsoprol
DE60214012D1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
WO2002008194A8 (fr) Derives acridine et utilisation en tant qu'agents pharmaceutiques
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
HU9600654D0 (en) Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
WO2001032132A3 (fr) Procede de preparation de pate dentifrice a l'aide de polymeres agglomeres pouvant se disperser
HUP0203238A3 (en) Drugs for the treatment of malignant tumours, process for their preparation and pharmaceutical compositions containing them
PT1003496E (pt) Medicamento para tratamento de neoplasia intra-epitelial prostatica
ZA200306541B (en) Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin.
IL150528A0 (en) Ibuprofen containing active agent preparation
SI1374906T1 (sl) Postopek za pripravo inkluzijskih spojin piroksakama: beta-ciklodekstrina
TR200003302T2 (tr) Anti-astım, anti-alerjik, anti-enflamatuar, bağışıklık düzenleyici ve nöro-koruyucu etkiye sahip yeni 1,2,5-trisübstitüe edilmiş 1,2-dihidroindazol-3-onlar, bunların hazırlanması için işlem ve bunların ilaç olarak kullanımı.
ATE372774T1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
CA2212207A1 (fr) Utilisation de derives d'isoxazole et de crotonamide pour la modulation de l'apoptose
DE60142541D1 (de) Arzneimittel und dessen herstellungsprozess
ZA200002583B (en) Catalyst components for the polymerization of dienes, catalyst obtained therefrom, and process for the preparation of polydienes using the same.
ATE151962T1 (de) Panierkrumen überzug-zusammensetzung
MXPA03009681A (es) METODO PARA TRATAMIENTO DE TUMORES POR ADMINISTRACIoN DE TEGAFUR, URACILO, ACIDO FOLINICO, Y CICLOFOSFAMIDA.
IL159122A0 (en) Allylmercaptocaptopril compounds and uses thereof
ES2188336A1 (es) Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.
EP1437141A4 (fr) Traitements de la perte osseuse
ATE275401T1 (de) Herstellung von inogatran-agglomeraten und die verbindung inogatran-anhydrid
WO2001060344A3 (fr) Utilisation de thiamphenicol dans preparation compositions pharmaceutiques utiles dans le traitement des infections par des staphylocoques resistant aux intermediaires de vancomycine multiresistants
ZA997352B (en) Therapeutic agent for preventing and/or treating sepsis.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20071204

Year of fee payment: 6

OBST Application withdrawn